Connect with us

Now

Surgery On Conjoined Twins Is Successful Thanks To 3-D Printing

Published

on

twins

The technology of 3-d printing has been used in different industries and we have already seen how useful it can be in terms of possibly making life much easier. This time, the prominent technology has been used to ensure the success of a surgery that was done on conjoined twins in Qatar.

The surgery took nine hours, but thankfully, Hamad and Tamim were both survivors and managed to get through the surgery. The 3-d technology was used in simulations that were conducted before the actual surgery. The 3-d model replicated the twins’ abdomen and liver, which made it easier for the surgeons to anticipated the process of the surgery. You may check the link to the video below.

 

Link to video: https://youtu.be/h4rcptB1enU

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Now

AstraZeneca COVID-19 vaccine Shows 90% Effectiveness With No Serious Side Effects

Published

on

By

AstraZeneca announced today the effectiveness of its Covid-19 vaccine and it turned out to be around 90% effective with no serious side effects!

According to data from the late-stage trials in Britain and Brazil, the vaccine, which is developed by Oxford University, has shown 90% effectiveness after being administered as a a half dose followed by a full dose at least one month apart.

“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” Pascal Soriot, Astra’s chief executive, said in a statement.

British Prime minister Boris Johnson said it was “incredibly exciting news the Oxford vaccine has proved so effective in trials.”

The next step now is for the company to start preparing regulatory submission of the data to authorities across the world that have a framework in place for conditional or early approval.

It will also seek an emergency use listing from the World Health Organization (WHO) to speed up availability in countries with low income. In parallel, the full analysis of the interim results is being submitted for publication in a peer-reviewed journal.

With both Oxford’s and Pfizer’s vaccines, we can be hopeful that the new year will come bearing good news!

Continue Reading

Now

Another Coronavirus Vaccine By Moderna Shows 94.5% Effectiveness!

Published

on

By

Yet another promising news for a Covid-19 vaccine has been announced! Moderna said today that its vaccine has shown 94.5% effectiveness in preventing the virus, according to an analysis of its clinical trial.

The biotech company made the announcement earlier today, giving us a dash of hope amidst this coronavirus scare.

The news follows the announcement made by Pfizer and BioNTech, who said their vaccine was more than 90% effective.

The results come from interim analyses of intensive clinical studies. The clinical trials of Moderna saw the participation of 30,000 volunteers. Half got two doses of the vaccine 28 days apart, half got two shots of a placebo on the same schedule.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stéphane Bancel, chief executive officer of Moderna, in a statement.

Both companies used the same technology in making the vaccines, which is a tech based on a molecule known as mRNA, or messenger RNA. That molecule contains genetic instructions for making proteins inside cells.

We hope that by the end of this year, we can rest assured that a vaccine can soon end this pandemic.

Continue Reading

Now

Hopes Rise As Pfizer Announces That Its COVID-19 Vaccine is 90% Effective

Published

on

By

Hope rises as pharmaceutical giant Pfizer announced that its COVID-19 vaccine has successfully prevented 90% of the virus, a promising result that exceeded experts’ expectations!

This analysis is based on 94 cases of infection with SARS-CoV-2, the virus responsible for causing COVID-19, among both the vaccinated and placebo groups. The results included data from 38,955 of the total 43,538 volunteers who enrolled.

This makes Pfizer the very first company to release results from its Covid-19 vaccine, these findings are a result of collected seven days after the second of Pfizer’s two-shot regimen.

 

 

Continue Reading
Event calender
Cinema calender

Cinema calender

Facebook

Fashion

Categories

Top Posts

Trending

X